
The shift to Patient 360
Most systems screen patients using static inclusion and exclusion criteria. Elara reasons. We approach recruitment through a holistic lens, viewing each patient as a complete clinical story rather than isolated data points. By synthesizing structured records, clinical notes, laboratory results, and historical context, Elara helps research teams make clearer and more confident eligibility decisions. Instead of filtering data, Elara interprets clinical context.
Elara evaluates the patient’s full clinical picture :
Longitudinal history across encounters
Comorbidities and treatment pathways
Medication timelines and treatment responses
Disease progression
patterns
Physician notes and contextual clinical signals
Higher-Quality Matches
Identifies patients who truly align with complex protocol criteria by reasoning across clinical context rather than simple rule filters.
Reduced Protocol Deviations
Improves eligibility accuracy by evaluating full patient history, reducing the likelihood of enrolling patients who later fail protocol criteria.
Improved Patient Experience
Helps coordinators focus on meaningful patient engagement instead of repetitive chart reviews and manual screening processes.
More Predictable Enrollment
Provides clearer eligibility insights that help research teams plan recruitment more confidently across sites and study phases.
Proven at Scale
Enrollment Efficiency
0x
0x
More qualified patient leads identified through continuous eligibility reasoning across real-world clinical data.
Screening Accuracy
0%
0%
Reduction in screening failures by pre-qualifying patients before coordinator review.
Operational Relief
0%
0%
Less manual chart review required, allowing teams to focus on patient engagement.
Multi-Site Adoption
0+
0+
Clinical research sites actively using Elara across ongoing studies and trial phases.
Capabilities
Elara goes beyond search and automation. It enables research teams to reason through trial complexity, surface the right patients earlier, and operate with confidence across feasibility, screening, and enrollment.
High-fidelity patient matching
Accurately identifies eligible patients by reasoning through clinical context, exclusions, and time-based criteria not just keywords.
Protocol-driven feasibility
Interprets complex protocols to assess real patient availability, helping teams validate feasibility before trials are activated.
Multi-modal data synthesis
Brings together EHRs, clinical notes, lab results, and reports to form a complete, actionable patient picture.
Coordinator-ready workflows
Delivers pre-qualified cohorts so coordinators spend less time screening and more time engaging with patients.

Elara Align
Total Data sovereignty
We share the answer, not the record. Patient data never leaves the site firewall
Instant Intelligence
Visualize impact of criteria changes instantly with blind protocol simulation
Confident Compliance
Automated processing ensures full HIPAA safety with zero manual site workload
Trial Lifecycle
Supporting every phase
of a clinical trial
Elara supports clinical research teams across the full trial lifecycle, adapting to changing protocols, evolving patient data, and real-world operational needs without disrupting existing workflows.
Protocol Design & Review
Elara helps teams interpret complex inclusion and exclusion criteria early, bringing clarity before feasibility discussions begin.
Feasibility Assessment
Evaluates real-world patient data against protocol requirements to understand population availability and potential constraints.
Site Selection & Readiness
Supports site evaluation by aligning protocol needs with site-level data availability and patient demographics.
Patient Identification
Continuously reasons over clinical data to surface patients who meet eligibility criteria as records evolve.
Screening & Pre-Qualification
Delivers pre-qualified patient lists to coordinators, helping teams focus on patients most likely to proceed.
Enrollment Monitoring & Adjustment
Supports ongoing oversight by highlighting shifts in eligibility patterns as trials progress.



